Skip to content

Revenue at other companies

HTF
Heartflow, Inc. Common StockHTFL
$52.59M+41.3%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$666.95M-53.0%
DJT
Trump Media & Technology GroupDJT
$871.2K+6.1%
ADMA Biologics logo
ADMA BiologicsADMA
$114.49M-0.3%
Minerals Technologies logo
Minerals TechnologiesMTX
$546.9M+11.2%
Lincoln Educational Services Corporation logo
Lincoln Educational Services CorporationLINC
$143.96M+22.5%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's revenue?
Aurinia Pharmaceuticals (AUPH) reported revenue of $77.71M in Q1 2026.
How has Aurinia Pharmaceuticals's revenue changed year-over-year?
Aurinia Pharmaceuticals's revenue increased by 24.4% year-over-year, from $62.47M to $77.71M.
What is the long-term trend for Aurinia Pharmaceuticals's revenue?
Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's revenue has grown at a 57.8% compound annual growth rate (CAGR), from $45.61M to $283.06M.